image
NEXGEL, Inc. NXGL
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
Watchlist
$ 3.06
-3.77 %
$ 19.4 M
Market Cap
-5.37
P/E
CASH FLOW STATEMENT
-3.24 M OPERATING CASH FLOW
-8.16%
Growth Rates
1Year -8.16%
3Years -21.57%
5Years -15.95%
7Years -13.70%
10Years 0.00%
4.46 M INVESTING CASH FLOW
179.64%
Growth Rates
1Year 179.64%
3Years 153.46%
5Years 0.00%
7Years 0.00%
10Years 0.00%
379 K FINANCING CASH FLOW
110.35%
Growth Rates
1Year 110.35%
3Years -41.41%
5Years -24.49%
7Years -16.30%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis NEXGEL, Inc.
image
Net Income -3.16 M
Depreciation & Amortization 443 K
Capital Expenditures -696 K
Stock-Based Compensation 217 K
Change in Working Capital -421 K
Others -536 K
Free Cash Flow -3.93 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income (3.2) (4.7) (4.3) (2.3) (1.9) (1.9) (1.0) (1.8)
Depreciation & Amortization 0.4 0.3 0.1 50 K 67 K 0.3 0.3 0.3
Deferred Income Tax 0 0 (0.2) 2 K 0 0 16 K 63 K
Stock Based Compensation 0.2 0.3 0.3 0.2 4 K 0.2 7 K 12 K
Other Operating Activities (0.3) 1.4 2.0 2 K 1 K 14 K 8 K 9 K
Change in Working Capital (0.4) (0.2) (0.6) 0.2 39 K 36 K (0.1) 0.2
Cash From Operations (3.2) (3.0) (2.8) (1.8) (1.8) (1.5) (0.8) (1.3)
INVESTING CASH FLOW
Capital Expenditures (0.7) 96 K (0.3) (0.3) 0 0 7 K 0
Other Items 5.2 (5.5) 0 0 0 0 0 0
Cash From Investing Activities 4.5 (5.6) (0.3) (0.3) 0 0 7 K 0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0
Total Debt Repaid 0.6 (3.7) 3.0 0.5 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities (0.2) 0 (0.1) 1.4 1.3 1.5 0.8 1.3
Cash From Financing Activities 0.4 (3.7) 16.3 1.9 2.1 1.5 0.8 1.3
CHANGE IN CASH
Net Change In Cash 1.6 (12.2) 13.3 (0.2) 0.3 0 0 0
FREE CASH FLOW
Free Cash Flow (3.9) (3.1) (3.0) (2.1) (1.8) (1.5) (0.8) (1.3)